Article Details
Retrieved on: 2018-04-28 07:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Millennium Management</b> LLC bought a new stake in Enanta Pharmaceuticals (NASDAQ:ENTA) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 220,845 shares of the biotechnology ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here